Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Intrahepatic Reinfusion of Highly Purified CD133+ Stem Cells in Patients With End-Stage Liver Disease

NCT01025622 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT01025622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Intrahepatic Reinfusion of Highly Purified CD133+ Stem Cells in Patients With End-Stage Liver Disease
Lead sponsor
University of Bologna
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2009
Completion date
June 30, 2012
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis